MEDINCELL SA revenue for the last year amounted to 9.03 M EUR, the most of which — 9.03 M EUR — came from its highest performing source at the moment, Long-acting Injectable Drugs, the year earlier bringing 9.89 M EUR. The greatest contribution to the revenue figure was made by France — last year it brought MEDINCELL SA 9.03 M EUR, and the year before that — 9.89 M EUR.